Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Regulation FD disclosure
  3. 4 Open-market sale Director sold 5,000 shares at $18.50 ($92,500)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 8-K Event Executive or director change
  10. SC 13G/A Stake Amended Statement of Ownership
  11. UPLOAD Other SEC-generated Letter
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. 4 Open-market sale President & CEO sold 184,000 shares at $15.04 ($2,767,360)
  14. 4/A Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
  15. 4/A Grant or award Chief Commercial Officer acquired 80,000 shares (grant or award)
  16. 4/A Grant or award Chief Legal Officer acquired 55,000 shares (grant or award)
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 8-K Event Regulation FD disclosure
  19. 4 Grant or award Exec. Director, Finance - PAO acquired 5,850 shares (grant or award)
  20. 4 Grant or award Chief Commercial Officer acquired 125,000 shares (grant or award)

Page 19 of 99 · 1,967 filings